transplant

2 Comments

Generex Biotechnology: Oral-lyn Buccal Insulin Takes Center Stage [view article]
As both a kidney and pancreas transplant patient, I was delighted to hear that Generex is still moving forward with its Oral-lyn. I am at higher risk for cancer due to the immuno drugs I take everyday, so I would be adverse to ever trying Pfizer's formulation. Generex seens to offer me hope that as my pancreas becomes less efficient (as is happening to me now) and I require insulin once again, there may still be a needle-free alternative on the way. I'm sure I speak for many diabetics when I say to Generex, "Keep going!" Thanks to Mr. Steffens for such an informative article!! Apr 20 08:26 PM
Generex Biotechnology: Oral-lyn Buccal Insulin Takes Center Stage [view article]
Speaking as a kidney and pancreas transplant patient, I am delighted to hear that Generex is still pursuing Oral-lyn. Since cancer is a huge risk for me due to the immuno drugs I take, I would stay far away from Pfizer's formulation. Generex seems to offer some hope that as my pancreas becomes less efficient (as is happening to me now) and I need insulin once again, there is still a chance for needle-free delivery. Thanks to Nr. Steffens for this informative article!! Apr 20 08:18 PM

Symbols:

Authors:

More Transcripts»

Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »

Employers: See all recruitment options, get applications online or by email Post a job »